Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glen A Doherty

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Expert Opinion on Biological Therapy|May 4, 2019
Why do we need to improve monitoring of patients with inflammatory bowel disease (IBD) on biologic treatment?Ciara Egan, Glen A Doherty
Expert Opinion on Therapeutic Targets|February 25, 2009
Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?Glen A Doherty, Frank E Murray
Clinical and Experimental Gastroenterology|June 23, 2011
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's diseaseGlen A Doherty, Mark A Peppercorn
Expert Review of Gastroenterology & Hepatology|August 14, 2009
Management of acute severe ulcerative colitisGlen A Doherty, Adam S Cheifetz
World Journal of Gastrointestinal Endoscopy|January 3, 2017
Endoscopic evaluation in diagnosis and management of inflammatory bowel diseaseCarthage P Moran, Barra Neary, Glen A Doherty
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 20, 2013
Hydroxylases as therapeutic targets in inflammatory bowel diseaseEoin P Cummins, Glen A Doherty, Cormac T Taylor
Inflammatory Bowel Diseases|August 1, 2013
Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel diseaseDavid J Gibson, Elizabeth J Ryan, Glen A Doherty
International Journal of Colorectal Disease|March 12, 2013
A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn's diseaseJohn P Burke, Glen A Doherty, P Ronan O'Connell
Value in Health Regional Issues|March 12, 2026
Health-Related Quality of Life Among Adults With Inflammatory Bowel Disease in Ireland: A Cross-Sectional Study Using the EQ-5D-5LKristian P Mallon, Glen A Doherty, Richéal M Burns
World Journal of Gastroenterology|April 19, 2014
Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammationChun Seng Lee, Elizabeth J Ryan, Glen A Doherty
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|May 4, 2019
Why do we need to improve monitoring of patients with inflammatory bowel disease (IBD) on biologic treatment?Ciara Egan, Glen A Doherty
Expert Opinion on Therapeutic Targets|February 25, 2009
Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?Glen A Doherty, Frank E Murray
Clinical and Experimental Gastroenterology|June 23, 2011
Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's diseaseGlen A Doherty, Mark A Peppercorn
Expert Review of Gastroenterology & Hepatology|August 14, 2009
Management of acute severe ulcerative colitisGlen A Doherty, Adam S Cheifetz
World Journal of Gastrointestinal Endoscopy|January 3, 2017
Endoscopic evaluation in diagnosis and management of inflammatory bowel diseaseCarthage P Moran, Barra Neary, Glen A Doherty
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 20, 2013
Hydroxylases as therapeutic targets in inflammatory bowel diseaseEoin P Cummins, Glen A Doherty, Cormac T Taylor
Inflammatory Bowel Diseases|August 1, 2013
Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel diseaseDavid J Gibson, Elizabeth J Ryan, Glen A Doherty
International Journal of Colorectal Disease|March 12, 2013
A survey of current practices used to maintain surgically induced remission following intestinal resection for Crohn's diseaseJohn P Burke, Glen A Doherty, P Ronan O'Connell
Value in Health Regional Issues|March 12, 2026
Health-Related Quality of Life Among Adults With Inflammatory Bowel Disease in Ireland: A Cross-Sectional Study Using the EQ-5D-5LKristian P Mallon, Glen A Doherty, Richéal M Burns
World Journal of Gastroenterology|April 19, 2014
Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammationChun Seng Lee, Elizabeth J Ryan, Glen A Doherty
Pageof 6